Overactive Bladder – Global Clinical Trial Pipeline Highlights, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Overactive
Bladder – Global Clinical Trial Pipeline Highlights, 2019”
report has been added to ResearchAndMarkets.com’s
offering.

This report provides most up-to-date information on key pipeline
products in the global Overactive Bladder market. It covers emerging
therapies for Overactive Bladder in active clinical development stages
including early and late stage clinical trials.

The pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.

Clinical Trial Stages

The report provides Overactive Bladder pipeline products by clinical
trial stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.

Drug Mechanism Classes

The report provides Overactive Bladder pipeline products by their
dominant mechanism of action/drug class. This helps executives
categorize products based on their drug class and also assess the
strengths and weaknesses of compounds.

Company

The report provides Overactive Bladder pipeline products by the company.

Short-term Launch Highlights

Find out which Overactive Bladder pipeline products will be launched in
the US and Ex-US till 2024.

Key Topics Covered

1. Overactive Bladder Pipeline by Stages

2. Overactive Bladder Phase 3 Clinical Trial Insights

3. Overactive Bladder Phase 2 Clinical Trial Insights

4. Overactive Bladder Phase 1 Clinical Trial Insights

5. Overactive Bladder Preclinical Research Insights

6. Overactive Bladder Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables

Table 1: Overactive Bladder Phase 3 Clinical Trials, 2019

Table 2: Overactive Bladder Phase 2 Clinical Trials, 2019

Table 3: Overactive Bladder Phase 1 Clinical Trials, 2019

Table 4: Overactive Bladder Preclinical Research, 2019

Table 5: Overactive Bladder Discovery Stage, 2019

List of Figures

Figure 1: Overactive Bladder Pipeline Molecules by Clinical Trials
Stage, 2019

Figure 2: Overactive Bladder Phase 3 Clinical Trial Highlights, 2019

Figure 3: Overactive Bladder Phase 2 Clinical Trial Highlights, 2019

Figure 4: Overactive Bladder Phase 1 Clinical Trial Highlights, 2019

Figure 5: Overactive Bladder Preclinical Research Highlights, 2019

Figure 6: Overactive Bladder Discovery Stage Highlights, 2019

For more information about this report visit https://www.researchandmarkets.com/r/w44n9c

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Urological
Disorders Drugs